annelb
06-17-2008, 07:47 PM
FDA is notifying healthcare professionals that both conventional and atypical antipsychotics are associated with an increased risk of mortality in elderly patients treated for dementia-related psychosis.
http://www.fda.gov/cder/drug/InfoSheets/HCP/antipsychotics_conventional.htm
Anne
http://www.fda.gov/cder/drug/InfoSheets/HCP/antipsychotics_conventional.htm
Anne